Many Princeton people will remember Paul Scharf. He pushed carts at McCaffrey’s, he came to the HUB, a Saturday night social activity at Princeton United Methodist Church, he attended services there.
In Richard K. Rein’s U.S. 1 Newspaper column this week is an account of an end-of-life experience that should NOT be happening. Paul could have been encouraged to sign an Advanced Care Directive (available at Princeton Senior Resource Center) or, better, to sign a POLST form. It could have prevented his medical team at a nursing home from having to sustain his unsustainable life. A POLST form (Practitioner Orders for Life Sustaining Treatment) is not required by law, but in New Jersey it is strongly recommended.
Paul can no longer talk to tell what he wants.
On Thursday March 8 the Princeton Regional Chamber hosts Lori Gustave for its membership lunch at the Forrestal Marriott Gustave is VP of business development at Penn Medicine, which has taken over (officially, merged with) University Medical Center. If you think you might be sick in the next couple of years, you might want to hear how about how Penn Medicine uses an
“advanced care strategy” and organizes it around the patient’s disease or condition.
As for me, for the next few months, I will not focus hospitals, medical care, nursing facilities. Somebody can tell me what she said.
The Guaranteed Minimum Income plan, or Universal Basic Income, is not new. It was researched by a Princeton company, Mathematica Policy Research (MPR), back in 1969. It’s the subject of Diccon Hyatt’s excellent cover story “Driven by Data” in this week’s U.S. 1 Newspaper.
Led by Paul Decker, MPR is a company I’m proud to have in Princeton.
Today’s healthcare news:
I’ll start with Juliet Eilperin’s coverage of the healthcare bill in the Washington Post, “From hospitals, doctors, and patients, a last gasp of opposition to the Senate health-care bill,” A Daily Princetonian alumna, the Post’s senior national affairs correspondent, she tells of how hospitals have mounted unusual lobbying efforts. ‘While McConnell had been pressing for a vote on the measure before the end of June, the delay gave opponents more time to marshal their arguments and make their case to lawmakers. This final lobbying push represents opponents’ best chance of derailing McConnell’s final drive to passage, which continues to look uncertain.’
Today the CEO of Incyte, Herve Hoppenot, speaks at the Princeton Regional chamber lunch. Look for me in a striped jacket. At age six I ‘worked’ in my parents’ cancer research lab and 70 years later I have a vested interest in new cancer cures.
Second prize winner
First prize winner
Chris Owens, Joe Montemarano, Lou Wagman
Diccon Hyatt interviews Joe Montemarano
Techies play in a high stakes intramural tournament every February at one of the state’s best – free — networking opportunities. On February 15. at Princeton Innovation Forum (PrincetonIF) the Andlinger Center for Energy and the Environment, they gave away $30,000 in one afternoon. All the teams were from Princeton University with Princeton profs as advisors or main participants. Sponsored by the Keller Center, PrincetonIF focuses on commercializing technology developed at Princeton University.
Diccon Hyatt made it the cover story in this week’s issue of U.S. 1. It reads best in hard copy, so grab one today from a newsbox before it gets replaced tomorrow. Or read it here.
With angels, venture capitalists, lawyers, and supporters watching, each team made a three-minute pitch. Then that power crowd emptied out into the crowded lobby, mobbed the wine bar, and the noise level rose as those-in-the-know and those-with-money interviewed the presenters and each other.
My favorite moment was introducing Chris Owens of Oppenheimer Nexus to Lou Wagman and Joe Montemarano (photo top right). More on that in another post. Also (apparently I can’t control random order) are photos of second prize winner Niraj Jha, professor of electrical engineering, who is working on Internet security; first prize winner Robert Pagels presenting his technology for manufacturing microparticles for delivering biologic drugs; Pagels and his team get their pictures taken, and U.S. 1’s Diccon Hyatt interviews Joe Montemarano.
Read the story here to learn about exciting technology and get on the Keller Center’s mailing list here. Always something exciting going on at the Equad.
A friend wrote to me, jubilant, because her husband – diagnosed with a prostate problem — had researched and found a state of the art therapy “green light laser prostate therapy.” it worked wonderfully, she says. Apparently it is not available here in Princeton.
I urged her to try to share this news with others through a social media strategy, participatory medicine. Read about it here on medium. If you can’t get into the medium site, try this one.
For the experts — what participatory medicine platform would be best for prostate therapy recommendations?
“There are few sectors as resistant to change as government and health care,” says Susannah Fox, CTO of the Department of Health and Human Services. Her interview with Laura Landro is in the Wall Street Journal today. “We count on their stability. But I have seen those two millstones grind a great idea down to powder. I’ve also seen initiatives flourish and grow, nurtured on the strong platform that this agency provides.”
Here is the interview.
My take: In this election season, the image of government-as-inexorably-slow-millstone actually offers a modicum of comfort.
Disclosure: She is my daughter.
Above: Millstones from Evans Pharmaceutical Laboratories, Fleet Street, Liverpool. Used for grinding drugs from c.1846-1948. Catalyst Science Discovery Centre.
Photo by Mike Peel (www.mikepeel.net)., CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=42180642